Future research will focus on the specific regulatory mechanisms of the gut microbiota and IL-17 in the context of periodontitis and T2DM comorbidity, providing theoretical support for the role of the "oral-gut-immune axis" in glucose metabolism regulation. This evidence concerns the gene IL17A and type 2 diabetes mellitus.